Correlation Between Cathay Biotech and Meinian Onehealth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cathay Biotech and Meinian Onehealth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cathay Biotech and Meinian Onehealth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cathay Biotech and Meinian Onehealth Healthcare, you can compare the effects of market volatilities on Cathay Biotech and Meinian Onehealth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cathay Biotech with a short position of Meinian Onehealth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cathay Biotech and Meinian Onehealth.

Diversification Opportunities for Cathay Biotech and Meinian Onehealth

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cathay and Meinian is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cathay Biotech and Meinian Onehealth Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Meinian Onehealth and Cathay Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cathay Biotech are associated (or correlated) with Meinian Onehealth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Meinian Onehealth has no effect on the direction of Cathay Biotech i.e., Cathay Biotech and Meinian Onehealth go up and down completely randomly.

Pair Corralation between Cathay Biotech and Meinian Onehealth

Assuming the 90 days trading horizon Cathay Biotech is expected to under-perform the Meinian Onehealth. But the stock apears to be less risky and, when comparing its historical volatility, Cathay Biotech is 1.24 times less risky than Meinian Onehealth. The stock trades about -0.25 of its potential returns per unit of risk. The Meinian Onehealth Healthcare is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  489.00  in Meinian Onehealth Healthcare on September 15, 2024 and sell it today you would earn a total of  38.00  from holding Meinian Onehealth Healthcare or generate 7.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cathay Biotech  vs.  Meinian Onehealth Healthcare

 Performance 
       Timeline  
Cathay Biotech 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cathay Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cathay Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.
Meinian Onehealth 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Meinian Onehealth Healthcare are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Meinian Onehealth sustained solid returns over the last few months and may actually be approaching a breakup point.

Cathay Biotech and Meinian Onehealth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cathay Biotech and Meinian Onehealth

The main advantage of trading using opposite Cathay Biotech and Meinian Onehealth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cathay Biotech position performs unexpectedly, Meinian Onehealth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Meinian Onehealth will offset losses from the drop in Meinian Onehealth's long position.
The idea behind Cathay Biotech and Meinian Onehealth Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Transaction History
View history of all your transactions and understand their impact on performance